Zepp Health Corporation (ZEPP)
NYSE: ZEPP
· Real-Time Price · USD
2.80
-0.04 (-1.41%)
At close: May 13, 2025, 3:56 PM
2.46
-12.14%
Pre-market: May 14, 2025, 08:00 AM EDT
Zepp Health Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|
| Manufactured Product, Other Revenue | 1.85B | 2.45B | 4.44B | 4.19B |
| Manufactured Product, Other Revenue Growth | -24.34% | -44.89% | +5.83% | n/a |
| Product Revenue | 644.88M | 1.7B | n/a | n/a |
| Product Revenue Growth | -62.00% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 19.81M | 18.92M | 111.97M | 123.27M | 122.98M | 118.59M | 125.62M | 135.88M | 178.46M | 176.56M | 179.95M | 161.27M | 216.8M | 152.61M | 171.13M | 156.07M | 181.37M | 206.6M | 126.77M | 105.73M | 145.32M | 126.21M | 91.44M | 67.47M | 92.68M | 100.31M | 53.51M | 64.01M | 46.75M | 37.27M | 35.99M | 38.89M | 46.62M |
| Selling, General, and Administrative Revenue Growth | +4.67% | -83.10% | -9.17% | +0.24% | +3.70% | -5.60% | -7.55% | -23.86% | +1.07% | -1.88% | +11.59% | -25.62% | +42.06% | -10.82% | +9.65% | -13.95% | -12.22% | +62.98% | +19.90% | -27.25% | +15.14% | +38.03% | +35.51% | -27.20% | -7.61% | +87.47% | -16.41% | +36.91% | +25.43% | +3.56% | -7.46% | -16.58% | n/a |
| Research and Development Revenue | 11.06M | 10.86M | 78.61M | 96.14M | 80M | 74.64M | 89.29M | 117.87M | 114.34M | 127.38M | 128.99M | 146.41M | 93.78M | 108.66M | 160.3M | 152.33M | 129.57M | 172.89M | 117.21M | 118.34M | 140.15M | 124.54M | 93.75M | 72.38M | 85.07M | 59.96M | 44.35M | 73.84M | 45.24M | 35.24M | 32.84M | 40.5M | 34.3M |
| Research and Development Revenue Growth | +1.86% | -86.19% | -18.23% | +20.17% | +7.18% | -16.41% | -24.25% | +3.09% | -10.24% | -1.25% | -11.90% | +56.11% | -13.69% | -32.21% | +5.23% | +17.56% | -25.05% | +47.51% | -0.95% | -15.57% | +12.54% | +32.84% | +29.53% | -14.92% | +41.88% | +35.18% | -39.93% | +63.22% | +28.35% | +7.31% | -18.91% | +18.10% | n/a |
| Sales and Marketing Revenue | 13.25M | 11.9M | 76.7M | 77.31M | 86.47M | 70.56M | 71.55M | 85.98M | 125.09M | 123.85M | 108.25M | 103.11M | 152.1M | 90.7M | 104.69M | 90.79M | 116.85M | 115.62M | 71.34M | 54.84M | 62.76M | 56.63M | 40.41M | 22.18M | 28.75M | 32.34M | 20.7M | 14.74M | 14.35M | 9.9M | 9.39M | 10.39M | 13.02M |
| Sales and Marketing Revenue Growth | +11.39% | -84.49% | -0.79% | -10.59% | +22.54% | -1.38% | -16.78% | -31.27% | +1.00% | +14.41% | +4.99% | -32.21% | +67.69% | -13.36% | +15.31% | -22.31% | +1.07% | +62.06% | +30.08% | -12.61% | +10.82% | +40.16% | +82.14% | -22.85% | -11.09% | +56.21% | +40.46% | +2.75% | +44.97% | +5.38% | -9.64% | -20.18% | n/a |